Skip to main content
Log in

Lack of the serotonin transporter (SERT) reduces the ability of 5-hydroxytryptamine to lower blood pressure

  • Short Communication
  • Published:
Naunyn-Schmiedeberg's Archives of Pharmacology Aims and scope Submit manuscript

Abstract

Serotonin (5-hydroxytryptamine; 5-HT) is a potent constrictor of isolated blood vessels. However, recent studies demonstrate that chronic 5-HT infusion results in a prolonged fall in blood pressure in the rat. This finding highlights the need for further study of 5-HT in the cardiovascular system. We tested the hypothesis that a functional serotonin transporter (SERT) is critical to enabling a 5-HT-induced fall in blood pressure. Experiments were performed in male and female rats to determine whether gender significantly affected the ability of 5-HT to lower blood pressure and to determine whether SERT dependence was different in male vs. female rats. 5-HT (25 μg/kg/min; s.c.) was infused for 7 days to male and female, SERT wild-type (WT) and SERT knockout (KO) rats. Mean arterial pressure (MAP) and heart rate were monitored via radiotelemetry. 5-HT produced a significantly greater fall in MAP (at the nadir) in the male SERT WT rat (−20 ± 1 mmHg) compared to the male SERT KO rat (−10 ± 2 mmHg). Similarly, 5-HT also produced a significantly greater fall in MAP (at the nadir) in the female SERT WT rat (−19 ± 1 mmHg) compared to the female SERT KO rat (−15 ± 0.4 mmHg). While the lack of a functional SERT protein did not prevent a 5-HT-induced fall in blood pressure, it did reduce the ability of 5-HT to lower blood pressure in the male and female SERT rat, suggesting a potentially important role for SERT in producing a 5-HT-induced fall in blood pressure.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  • Brenner B, Harney JT, Ahmed BA, Jeffus BC, Unal R, Mehta JL, Kilic F (2007) Plasma serotonin levels and the platelet serotonin transporter. J Neurochem 102:206–215

    Article  PubMed  CAS  Google Scholar 

  • Chanrion B, Mannoury la Cour C, Bertaso F, Lerner-Natoli M, Freissmuth M, Millan MJ, Brockaert J, Martin P (2007) Physical interaction between the serotonin transporter and neuronal nitric oxide synthase underlies reciprocal modulation of their activity. PNAS 104:8119–8124

    Article  PubMed  CAS  Google Scholar 

  • Dahlstroem A, Fuxe K (1964) Evidence for the existence of monamine-containing neurons in the central nervous system. I. Demonstration of monamines in the cell bodies of brain stem neurons. Acta Physiol Scand 232(Suppl):1–55

    Google Scholar 

  • Diaz J, Ni W, Thompson J, King A, Fink G, Watts SW (2008) 5-hydroxytryptamine lowers blood pressure in normotensive and hypertensive rats. J Pharmacol Exp Ther 325:1031–1038

    Article  PubMed  CAS  Google Scholar 

  • Erspamer V, Aerso B (1952) Identification of enteramine, the specific hormone of the enterochromaffin cell system, as 5-hydroxytryptamine. Nature 169:800–801

    Article  PubMed  CAS  Google Scholar 

  • Fetkovska N, Pletscher A, Ferracin F, Amstein R, Buhler FR (1990) Impaired uptake of 5-hydroxytryptamine in platelet in essential hypertension: clinical relevance. Cardiovasc Drugs Ther 4:105–109

    Article  PubMed  Google Scholar 

  • Homberg JR, Olivier JDA, Smits BMG, Mul JD, Mudde J, Verheul NOFM, Cools AR, Ronken E, Cremers T, Schoffelmeer ANM, Ellenbroek BA, Cuppen E (2007) Characterization of the serotonin transporter knockout rat: a selective change in the functioning of the serotonergic system. Neuroscience 146:1662–1676

    Article  PubMed  CAS  Google Scholar 

  • Linder AE, Diaz J, Ni W, Szasz T, Burnett R, Watts SW (2008a) Vascular reactivity, 5-HT uptake, and blood pressure in the serotonin transporter knockout rat. Am J Physiol Heart Circ Physiol 294:H1745–H1752

    Article  PubMed  CAS  Google Scholar 

  • Linder AE, Ni W, Szasz T, Burnett R, Diaz J, Geddes TJ, Kuhn DM, Watts SW (2008b) A serotonergic system in veins: serotonin transporter-independent uptake. J Pharmacol Exp Ther 325:714–722

    Article  PubMed  CAS  Google Scholar 

  • Maron E, Toru I, Hirvonen J et al. (2011) Gender differences in brain serotonin transporter availability in panic disorder. J Psychopharmacol (in press)

  • Nakatani Y, Sato-Suzuki I, Tsujino N, Nakasato A, Seki Y, Fumoto M (2008) Augmented brain 5-HT crosses the blood–brain barrier through the 5-HT transporter in rat. Eur J Neurosci 27:2466–2472

    Article  PubMed  Google Scholar 

  • Ni W, Thompson JM, Northcott CA, Lookingland K, Watts SW (2004) The serotonin transporter is present and functional in peripheral arterial smooth muscle. J Cardiovasc Pharmacol 43:770–781

    Article  PubMed  CAS  Google Scholar 

  • Rapport MM, Green AA, Page IH (1948) Serum vasoconstrictor (serotonin): IV isolation and characterization. J Biol Chem 176:1243–1251

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Robert Patrick Davis.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Patrick Davis, R., Linder, A.E. & Watts, S.W. Lack of the serotonin transporter (SERT) reduces the ability of 5-hydroxytryptamine to lower blood pressure. Naunyn-Schmiedeberg's Arch Pharmacol 383, 543–546 (2011). https://doi.org/10.1007/s00210-011-0622-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00210-011-0622-1

Keywords

Navigation